Fingerprint
Dive into the research topics of 'Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: A randomized phase II cardiac safety study (TRYPHAENA)'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically